Gelonghui reported on December 4 that Limin Group (002734.SZ) expressed in a recent investor relations activity that the company's core products include Mancozeb and Bactericide, which have performed well in the market. After acquiring Weiyuan Biotechnology, the company strengthened its pesticide business and now has the third-largest domestic production capacity of Abamectin and 800 tons of Methomyl capacity. The market fill price of Abamectin has risen from 0.35-0.36 million yuan at the end of last year to 0.46 million yuan, an increase of nearly 30%. The price of Methomyl has increased from 0.46 million yuan to 0.65-0.66 million yuan, with products containing 95% showing even better price performance.